Merlini 2007.

Methods	Randomised, placebo‐controlled, double‐blind trial
Participants	110 participants with SMA types II or III, aged ≥ 4 years
Interventions	Acetyl‐L‐carnitine 50 mg/kg/day (maximum 3 g/day) (route not mentioned) or placebo Duration of treatment: 9 months Follow‐up: 12 months
Outcomes	Change in muscle strength arm and leg (myometry), change in functional score (time to walk 10 m and to arise from floor), change in pulmonary function (FVC), change in quality of life (Short Form‐36 Health Survey questionnaire (SF‐36) or Childhood Health Assessment Questionnaire.
Notes	Study status unknown (last report on trial notified in 2007). No results available